Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis

This publication has 47 references indexed in Scilit:

• Recent advances in the IL-17 cytokine family
  Current Opinion in Immunology, 2011
• Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis
  The Journal of Immunology, 2011
• Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
  The Journal of Immunology, 2011
• Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
  Science, 2011
• Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
  PLOS ONE, 2010
• Psoriasis
  New England Journal of Medicine, 2009
• Psoriasis associated with ulcerative colitis and Crohn's disease
  Journal of the European Academy of Dermatology and Venereology, 2009
• IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis
  Journal of Experimental Medicine, 2006
• Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17
  Journal of Biological Chemistry, 2003
• T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.
  Journal of Experimental Medicine, 1996